You are more than your cancer diagnosis. That’s why Oregon Urology Institute Radiation Center doesn’t just treat cancer – we treat you. Our caring doctors listen, help you understand your options and provide the most advanced treatments available.
Oregon Urology Institute Radiation Center is the Willamette Valley’s only cancer center dedicated to treating and researching urologic cancers. We offer the expertise of highly trained specialists; the most advanced treatments; and a full range of support services to guide you through your cancer treatment.
During radiation therapy, targeted energy is used to kill cancer cells or keep them from growing. Radiation therapy may be external, internal or systemic depending on what type and stage of cancer you have.
External radiation therapy uses a machine outside the body to point radiation toward the cancer. At Oregon Urology Institute Radiation Center, the only external radiation we use is highly-targeted Image-Guided Radiation Therapy (IGRT).
Systemic radiation is taken orally or injected. This type of radiation travels throughout the body until it reaches the targeted cancer cells. Oregon Urology Institute Radiation Center is currently the only radiation oncology practice in the Willamette Valley able to offer Xofigo, a radiation injection for advanced prostate cancer.
Learn more about different types of radiation and what to expect:
Image-Guided Radiation TherapyXofigo® Systemic Radiation
Immunotherapies work by stimulating your immune cells, or T-cells, to attack tumor cells. Your T-cells can be activated by injecting drugs or antibodies into your system, or your T-cells may be collected from your blood and reprogrammed to fight cancer cells in a laboratory. They are then re-injected into your system.
They then go to work attacking certain proteins found in cancer cells but not in normal cells. Because it doesn’t hurt normal cells, immunotherapy generally has few side effects.
Currently, our radiation center offers Immunotherapy for Prostate Cancer.
Learn more about Immunotherapy for Prostate Cancer